Bao, Y. and Yu, Y. 2023. Topotecan and Irinotecan as potential inhibitors of PARP-1. Highlights in Science, Engineering and Technology. 45, (Apr. 2023), 370–383. DOI:https://doi.org/10.54097/hset.v45i.7582.